This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Confidence in the company rose as shares for both AbbVie and its parent company, Abbott Laboratories, increased on the first day of trading in the New Year. AbbVie's stock opened yesterday at US $ ...

After spinning off from Abbott Labs in 2013, biopharmaceutical giant AbbVie had to establish its own culture. Here's how the ...

For years, the healthcare industry has been a cornerstone of the economy, offering resilience in both stable and uncertain ...

Even more alarming is AbbVie's payout ratio of 216.7%, far surpassing the peer average of 141%. This sky-high figure means ...

Regarding distributions, we view AbbVie’s dividends and share repurchases as about right. Since being divested from Abbott, AbbVie has largely focused on a dividend payout ratio close to 50% ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

Abbott's stock price has been doing well lately ... the dividend history has a big decline is because of the spin-off of AbbVie Inc. (ABBV) in 2012. Since the spin-off, AbbVie has raised its ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

17 long-term dividend growth companies will announce their annual increases in October. I provide predictions of the dividend ...

AbbVie became a stand-alone company in 2012 after it split from its former parent company, Abbott Laboratories. Since then, it has increased its payouts by an impressive 288%. When including the ...